- About CSAM
- Public Policy
Physicians dedicated to improving the treatment of substance use disorders. A State chapter of the American Society of Addiction Medicine.
Continuing Medical Education
Essentials of Addiction Medicine
This conference is one of the nation’s foremost annual gatherings of physicians and other healthcare professionals who specialize in the treatment of Substance Use Disorders (SUD) and practicing physicians in both primary care and other specialty fields who are seeking an overview of the field of Addiction Medicine.
CSAM Releases Papers on Minimum Insurance Benefits for Treatment of Substance Use Disorders
Californians with substance use disorders are grossly underserved. According to the 2007 state estimates from the National Survey on Drug Use and Health, 764,000 Californians needed but didn’t receive treatment for drug use and 2.3 million Californians needed but did not receive treatment for alcohol use. At the end of 2014, CSAM released the Consumer Guide and Scorecard for Health Insurance Coverage in California for Substance Use Disorders and Mental Health which revealed that insurance plans often do not meet minimum evidence-based standard for substance abuse treatment. In order to address this disparity, CSAM has produced three papers that propose minimum standards and document the evidence for these. CSAM plans to meet with insurance providers to discuss the gap between these minimum standard and what is currently provided. These papers were adopted by the CSAM Executive Council on May 19, 2016.
- Minimum Insurance Benefits for Patients with Opioid Use Disorder by David Kan, MD and Tauheed Zaman, MD
- Minimum Insurance Benefits for Patients with Alcohol Use Disorders by Anna Lembke, MD, David Kan, MD, and Tauheed Zaman, MD
- Minimum Insurance Benefits for Patients with Nicotine and Tobacco Use Disorder by Smita Das, MD, PhD, MPH, Cathy McDonald, MD, and Lori Karan, MD
Webinar: You've Got Your X-Number, Now What? Strategies to Increase Your Confidence with Buprenorphine Prescribing in Primary Care
June 2, 2016 - 12 pm
An estimated 30-70% of providers with the DEA waiver to treat opioid addiction with buprenorphine do not use it. The goal of this webinar is to review common problems encountered in buprenorphine prescribing via case vignettes. Approaches and strategies for these common challenges will be provided.
- Soraya Azari, MD, Assistant Professor, Department of Medicine, UCSF School of Medicine
- Scott Steiger, MD, Assistant Professor, Department of Medicine, UCSF School of Medicine
Addiction Medicine Now ABMS Recognized
March 14, 2016 -- The American Board of Medical Specialties (ABMS) has officially recognized Addiction Medicine as a subspecialty. The American Board of Preventive Medicine (ABPM), a Member Board of ABMS, sponsored the application for the new field to be a multispecialty subspecialty. Certification by an ABMS is considered the “gold standard” in physician credentialing, assuring patients that their physician meets the highest standards of practice and clinical knowledge, and has completed an approved educational program and process.
As part of the transition there will not be a Addiction Medicine Certification Exam in 2016. CSAM will offer Essentials of Addiction Medicine Course August 24-27, 2016 in Anaheim. This Course will feature nationally-recognized experts and is designed to prepare attendees for future Addiction Medicine Boards, provide a framework for those wanting to integrate addiction treatment into their primary care practice, and offer a refresher for experienced addiction medicine practitioners.
Available on the Online Education Center
Online Synapse to Society: Addiction Medicine State of the Art 2015
Held October 24-27 in San Francisco
27 lectures 16.5 AMA/PRA Category 1 Credits
Addiction Medicine Review Course and Certification Exam Preparation Track
Held September 3-6, 2014 in Anaheim
Review Course 16.5 AMA/PRA Category 1 Credits
Certification Exam Preparation Track 17 AMA/PRA Category 1 Credits
CSAM Cannabis Policy Statements
An initiative to legalize cannabis is highly likely to appear on the 2016 California ballot. In the advent of policy changes that may increase availability of cannabis, an addictive drug, what are credible and evidence-based positions that prevent addiction, prevent harm to vulnerable populations, and promote access to quality treatment? CSAM believes that it is not necessary to support an initiative to work toward ensuring that whatever initiative is presented or eventually adopted takes measures to mitigate public health harms associated with expanded access to and use of cannabis.
- CSAM has established recommendations for cannabis policy in the prospect of possible ballot initiatives legalizing cannabis in California. [Read CSAM recommendations]
- The Control. Regulate and Tax Adult Use of Marijuana Act (Initiative No. 15-0103) is one of several initiatives that are seeking a place on the 2016 ballot. CSAM has submitted comments to the initiative's drafters through the California Attorney General's Office. [Read CSAM comments]